The New York Times - Business:
Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.
Author: Andrew Jacobs
This post first appeared in The New York Times - Business. Read the original article.
